PEG-Based Hydrogels via Click Polymerization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current click hydrogel systems are challenging to implement due to synthetic difficulties, inefficient scalability, high cost, and complex protocols, making them inaccessible for broad use in biomaterials research and applications.
Innovation Solution
Development of a water-compatible variant of 'click' polymerization between alkynoates and secondary amines to form β-aminoacrylate synthetic polyethylene glycol (PEG)-based hydrogels, which are easy to formulate and scalable, with tunable gelation rates and cytocompatibility, eliminating the need for catalysts and specialized equipment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current click hydrogel systems are used, then tunable gelation and cytocompatibility are achieved, but synthetic difficulty and operational complexity increase
Solution Approach 1:
The patent employs commercially available, inexpensive starting materials (PEG alkynoate and amine compounds) that can be purchased off-the-shelf without requiring complex synthesis protocols. This eliminates the need for custom monomer synthesis while maintaining gelation control and cytocompatibility, directly addressing the contradiction between reliability and ease of manufacture.
Solution Approach 2:
The patent achieves tunable gelation rates by varying parameters such as polymer concentration, molecular weight of PEG, and composition ratios, rather than requiring complex synthesis modifications. This allows researchers to adjust gelation kinetics simply by changing formulation parameters, resolving the contradiction between achieving reliable cytocompatible gels and avoiding synthetic complexity.
2Adaptability or versatility
If current click hydrogel systems are used, then functional tunability is achieved, but cost and accessibility increase
Solution Approach 1:
The patent creates a universal hydrogel platform based on PEG-alkynoate and amine chemistry that can be used for multiple applications (tissue engineering, drug delivery, wound healing) without requiring application-specific synthesis. The system maintains functional tunability through simple formulation adjustments while being accessible to researchers without specialized synthesis capabilities or equipment.
Solution Approach 2:
By using commercially available starting materials and eliminating the need for expensive custom synthesis, the patent makes tunable hydrogel systems accessible to a broader research community. The inexpensive nature of the materials allows multiple formulations to be tested and optimized without significant cost barriers.
3Manufacturing precision
If current click hydrogel systems are used, then gelation control is achieved, but scalability and efficiency worsen
Solution Approach 1:
The patent uses pre-synthesized PEG-alkynoate macromers with controlled molecular weights and functionalities that are commercially available. This preliminary preparation of well-characterized starting materials enables scalable production while maintaining precise gelation control, as the gelation behavior is determined by simple mixing ratios rather than complex in-situ synthesis parameters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new hydrogel system offers improved user-friendliness and accessibility, enabling broad implementation in biomaterials research and applications, such as therapeutic delivery, tissue engineering, and wound healing, with high viability and tunable properties.
Implementation Method 1
a water-compatible variant of a 'click'-like polymerization between alkynoates and secondary amines to form β-aminoacrylate synthetic polyethylene glycol (PEG)-based hydrogels
Data Source
AI summary
Provided herein are polymers of Formula (I), and pharmaceutically acceptable salts, co-crystals, tautomers, stereoisomers, and isotopically labeled derivatives thereof, compositions, and formulations thereof. The polymers described herein are biocompatible, non-toxic, water compatible, and operationally simple to formulate. Also provided are methods and kits involving the polymers described herein (e.g., methods of using polymers described herein for delivering agents (e.g., for therapeutic, diagnostic, prophylactic, imaging, ophthalmic, intraoperative, or cosmetic use) to a subject, cell, tissue, or biological sample, as part of materials (e.g., biodegradable materials, biocompatible materials, wound dressing (e.g., bandages), drug depots, coatings), or as scaffolds for tissue engineering. Provided are methods for synthesizing the polymers described herein, and polymers described herein synthesized by the synthetic methods described herein.